Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-20-002868
Filing Date
2020-11-10
Accepted
2020-11-10 16:25:10
Documents
1
Period of Report
2020-11-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form412566001_11102020.html 4  
1 OWNERSHIP DOCUMENT form412566001_11102020.xml 4 3632
  Complete submission text file 0000921895-20-002868.txt   5214
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Reporting) CIK: 0001055919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 201301487

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations